Kane Biotech (KNE) News Today C$0.11 -0.01 (-4.35%) (As of 09:43 AM ET) Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound GelNovember 14, 2024 | markets.businessinsider.comKane Biotech Provides Investor Update Following FB Dermatology Acquisition AnnouncementNovember 14, 2024 | markets.businessinsider.comKane Biotech Announces Agreement to Acquire FB DermatologyNovember 12, 2024 | markets.businessinsider.comKane Biotech Announces Donation of revyve™ Antimicrobial Wound Gel to UkraineOctober 23, 2024 | markets.businessinsider.comPositive Signs As Multiple Insiders Buy Kane Biotech StockOctober 21, 2024 | finance.yahoo.comKane Biotech to distribute XSONX Wound Hygiene SystemOctober 19, 2024 | msn.comKane Biotech Announces Exclusive Distribution Agreement With XSONXOctober 17, 2024 | finance.yahoo.com'Positive development' - Harry Kane has no serious injurySeptember 30, 2024 | sports.yahoo.comKane Biotech Announces Attendance at Upcoming Wound Care ConferencesSeptember 26, 2024 | finance.yahoo.comKane Biotech Inc. (CVE:KNE) Director Buys C$11,250.00 in StockSeptember 18, 2024 | insidertrades.comKane Biotech Inc.September 17, 2024 | wsj.comKane Biotech Announces Exercise of WarrantsSeptember 12, 2024 | markets.businessinsider.comKane Biotech Inc.: Kane Biotech Announces Second Quarter 2024 Financial ResultsAugust 30, 2024 | finanznachrichten.deKane Biotech Announces new DispersinB® Publication in Pathogens and Conference PresentationsAugust 30, 2024 | tmcnet.comKane Biotech Announces Second Quarter 2024 Financial ResultsAugust 30, 2024 | markets.businessinsider.comKane Biotech Announces Distribution Agreement with Qatar Datamation Systems for revyve™ Antimicrobial Wound GelAugust 28, 2024 | finance.yahoo.comKane Biotech Announces Distribution Agreement with Razan Medical Trading for revyve(TM) Antimicrobial Wound GelAugust 24, 2024 | stockhouse.comKane Biotech Announces Distribution Agreement with Razan Medical Trading for revyve™ Antimicrobial Wound GelAugust 22, 2024 | finance.yahoo.comStocks in play: Talisker Resources Ltd.August 14, 2024 | ca.finance.yahoo.comKane Returns as Tottenham Clash with Bayern Munich In PreseasonAugust 9, 2024 | sports.yahoo.comInsider Buying: Kane Biotech Inc. (CVE:KNE) Director Buys 150,000 Shares of StockJuly 30, 2024 | insidertrades.comKane Biotech Inc.: Kane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyve Antimicrobial Wound GelJuly 23, 2024 | finanznachrichten.deKane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyve™ Antimicrobial Wound GelJuly 23, 2024 | finance.yahoo.comKane Biotech Receives ISO 13485:2016 MDSAP Quality CertificationJuly 19, 2024 | finance.yahoo.comKane Biotech Inc. (CVE:KNE) Director Purchases C$48,300.00 in StockJune 26, 2024 | insidertrades.comPatrick Kane is King William High's new athletics directorMay 28, 2024 | yahoo.comKane Biotech Inc.: Kane Biotech Announces First Quarter 2024 Financial ResultsMay 24, 2024 | finanznachrichten.deKane Biotech Announces First Quarter 2024 Financial ResultsMay 23, 2024 | finance.yahoo.comKane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound MapMay 15, 2024 | finance.yahoo.comHarry Kane on target but Vinicius Jr brace earns Real Madrid first-leg drawApril 30, 2024 | msn.comKane double steers Bayern 2-1 past Frankfurt ahead of Real clashApril 28, 2024 | reuters.comKane sets personal record with double in Bayern winApril 27, 2024 | msn.comKane Biotech Inc. (CVE:KNE) Director Sells C$260,000.00 in StockApril 23, 2024 | insidertrades.comKane Biotech Inc.: Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary ProductsApril 16, 2024 | finanznachrichten.deKane Biotech to Host Investor WebinarApril 16, 2024 | tmcnet.comDual Listed Biotech Firm Achieves Sale of Animal Health Interest, Sending Shares HigherApril 15, 2024 | msn.comKane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary ProductsApril 15, 2024 | stockhouse.com'Light Injuries': Harry Kane's Children In Munich Car AccidentApril 12, 2024 | barrons.comKane Biotech Inc.: Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal HealthApril 11, 2024 | finanznachrichten.deCanadian Investment Regulatory Organization Trading Halt - KNEApril 11, 2024 | ca.finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - KNEApril 11, 2024 | finance.yahoo.comKane Biotech Inc.: Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 29, 2024 | finanznachrichten.deKane Biotech Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 27, 2024 | finance.yahoo.comKane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal HealthMarch 20, 2024 | finance.yahoo.comKane Biotech Receives Bioscience Association Manitoba Company of the Year AwardMarch 8, 2024 | tmcnet.comChicago Blackhawks brace for Patrick Kane’s return — as a Detroit Red Wing: ‘It’s definitely weird’February 24, 2024 | msn.comKane Biotech Inc.: Kane Biotech Files New Patent on revyve Antimicrobial Wound Gel SprayJanuary 31, 2024 | finanznachrichten.deKane Biotech Files New Patent on revyve™ Antimicrobial Wound Gel SprayJanuary 31, 2024 | financialpost.comKane Biotech Files New Patent on revyve(TM) Antimicrobial Wound Gel SprayJanuary 31, 2024 | stockhouse.comKane Biotech to Present its revyve™ Antimicrobial Wound Gel at Boswick Burn and Wound Care SymposiumJanuary 25, 2024 | markets.businessinsider.com Get Kane Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KNE and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. KNE Media Mentions By Week KNE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KNE News Sentiment▼0.480.46▲Average Medical News Sentiment KNE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KNE Articles This Week▼21▲KNE Articles Average Week Get Kane Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KNE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Microbix Biosystems News Aeterna Zentaris News Sirona Biochem News Resverlogix News Hemostemix News Aptose Biosciences News Innovotech News Quest PharmaTech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:KNE) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kane Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kane Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KNE Stock Alerts